Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 17.5
(-0.91%)
CNY 17.5
(-0.91%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.44 Billion CNY | 18.34% |
| 2022 | 2.06 Billion CNY | 70.76% |
| 2021 | 1.21 Billion CNY | 50.57% |
| 2020 | 804.42 Million CNY | -1.62% |
| 2019 | 817.68 Million CNY | 32.94% |
| 2018 | 615.07 Million CNY | 27.26% |
| 2017 | 483.33 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.77 Billion CNY | 11.86% |
| 2024 Q3 | 2.69 Billion CNY | -2.71% |
| 2024 Q1 | 2.47 Billion CNY | 1.26% |
| 2023 Q3 | 2.21 Billion CNY | 5.18% |
| 2023 FY | 2.44 Billion CNY | 18.34% |
| 2023 Q4 | 2.44 Billion CNY | 10.49% |
| 2023 Q2 | 2.1 Billion CNY | 1.42% |
| 2023 Q1 | 2.07 Billion CNY | 0.42% |
| 2022 Q3 | 1.7 Billion CNY | -1.45% |
| 2022 Q2 | 1.72 Billion CNY | 29.7% |
| 2022 Q1 | 1.33 Billion CNY | 9.86% |
| 2022 FY | 2.06 Billion CNY | 70.76% |
| 2022 Q4 | 2.06 Billion CNY | 21.6% |
| 2021 Q4 | 1.21 Billion CNY | 14.76% |
| 2021 Q1 | 826.76 Million CNY | 2.78% |
| 2021 FY | 1.21 Billion CNY | 50.57% |
| 2021 Q3 | 1.05 Billion CNY | 1.01% |
| 2021 Q2 | 1.04 Billion CNY | 26.39% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 804.42 Million CNY | -1.62% |
| 2020 Q4 | 804.42 Million CNY | -1.45% |
| 2020 Q3 | 816.29 Million CNY | 3.41% |
| 2020 Q2 | 789.4 Million CNY | 0.0% |
| 2019 FY | 817.68 Million CNY | 32.94% |
| 2019 Q4 | 817.68 Million CNY | 0.0% |
| 2018 FY | 615.07 Million CNY | 27.26% |
| 2017 FY | 483.33 Million CNY | 0.0% |